Infusion of tiny mitochondria helps rejuvenate tissues, so researchers hope the technique could treat a variety of damaged ...

A preclinical study led by the Smidt Heart Institute at Cedars-Sinai challenges the assumption that blocking the NCX1 protein ...

Heart attacks remain a leading cause of death and disability worldwide. The permanent loss of heart muscle cells-known as ...

November 22, 2011 (Orlando, Florida) — Results from a small phase 1 study provide some reason for optimism in the treatment of ischemic cardiomyopathy with autologous cardiac stem cells (CSCs) [1].

Internationally-renowned cardiologist and scientist, Dr. Michael Gollob, and his research assistant Qiuju Li, conduct experiments to better understand how gene mutations change how heart cells ...

These trials, which lasted between three and six months, confirmed that the implants, which consist of 40 to 200 million heart cells, improve heart function.

By organizing the rest of the heart cell, cBIN1 helps restore critical functions of heart cells. "cBIN1 is bringing benefits to multiple signaling pathways," Li adds.

Human heart cells and tissues grown in the laboratory from stem cells promise to accelerate the development of drugs and treatments for heart disease, but they currently take weeks or months to ...

When they do happen, heart tumors can be quite serious and more aggressive than other cancers. A study analyzing more than ...